Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: Nashville TN, Atlanta GA, Toronto, Coral Springs FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase1, Recruiting

ELEVATE High-Risk PCI Pivotal Study

for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Location: Nashville TN, Marietta GA, Atlanta GA, Edgewood KY,
Sponsor: Magenta Medical Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07001332

Recruiting

HPC Offered for PRESERVE Expansion

for
Bone Marrow Transplant (BMT)
Location: Nashville TN, Birmingham AL, Columbus OH, Detroit MI
Sponsor: Ossium Health, Inc.

Sex: All

Age: 12 - 70+

Code: NCT07145411

Recruiting

Abbott Cephea Mitral Valve Disease Registry

for
Mitral Regurgitation, Mitral Stenosis, Mitral Valve Disease,
Location: Nashville TN, Birmingham AL, Atlanta GA,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT07069673

Recruiting

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: Nashville TN, Huntsville AL, Louisville KY,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Nashville TN, Birmingham AL, Atlanta GA, St Louis MO,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for
Obstructive Hypertrophic Cardiomyopathy
Location: Nashville TN, Tupelo MS, Cincinnati OH, Indianapolis IN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05489705

Recruiting

Delirium Reduction With Ramelteon

for
Delirium
Location: Nashville TN
Sponsor: Centennial Medical Center

Sex: All

Age: 18+

Code: NCT05069428

Recruiting

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

for
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Location: Nashville TN, Cincinnati OH, Detroit MI, Rochester MN,
Sponsor: Innoventric LTD

Sex: All

Age: 18 - 70+

Code: NCT06212193

Recruiting

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

for
Advanced Solid Tumors With MAPK Pathway Mutations
Location: Nashville TN, Detroit MI, Houston TX
Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All

Age: 18+

Code: NCT05886920

Phase1, Phase2, Recruiting

FORWARD CAD IDE Study

for
Coronary Arterial Disease (CAD)
Location: Nashville TN, Atlanta GA, Cincinnati OH, Raleigh NC,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT06662500

Recruiting

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

for
APOL1-Mediated Kidney Disease
Location: Nashville TN, Tupelo MS, Irondale AL, Birmingham AL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT06824987

Phase2, Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Nashville TN, Louisville KY, Birmingham AL, St Louis MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Nashville TN, Birmingham AL, Cincinnati OH,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase3, Recruiting

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

for
Relapsing Multiple Sclerosis
Location: Nashville TN, Smyrna GA, Wilmington NC, Boston MA,
Sponsor: TG Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT06143514

Recruiting

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

for
Down Syndrome, Down Syndrome, Partial Trisomy 21,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18 - 55

Code: NCT05231798

Phase2, Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Nashville TN, Lexington KY, St Louis MO, Columbus OH,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT07165132

Phase1, Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Nashville TN, Athens AL, Huntsville AL, Guntersville AL,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Nashville TN, Mount Juliet TN, Tennessee City TN,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for
Asthma
Location: Nashville TN, Louisville KY, Atlanta GA, Snellville GA,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase3, Recruiting